arrow
S

Saber Yezli

King Faisal Specialist Hospital and Research Centre
H指数:44
被引数:2.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Strengthening regional surveillance: MenMap Network's year 1 findings on bacterial meningitis in Jordan, Egypt, and Iraq (2023-2024)

加强区域监测:MenMap网络关于约旦、埃及和伊拉克细菌性脑膜炎的2023-2024年度1发现

2026-06-010
OAAI
RETRACTION: Acquisition of multidrug-resistant bacteria and encoding genes among French pilgrims during the 2017 and 2018 Hajj
2024-11-290
OA
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021

1990至2021 204个国家和地区以及811个地方的371疾病和伤害的全球发病率,患病率,残疾寿命 (YLDs),残疾调整寿命 (DALYs) 和健康预期寿命 (HALE): 全球疾病负担研究2021的系统分析

LANCET
IF88.5
2024-05-01285
OAAI
Global fertility in 204 countries and territories, 1950-2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021

1950至2021 204个国家和地区的全球生育率,预测到2100: 全球疾病负担研究2021的综合人口分析

LANCET
IF88.5
2024-05-0143
OAAI
Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021

2022至2050 204个国家和地区的疾病负担情景: 全球疾病负担研究2021的预测分析

LANCET
IF88.5
2024-05-0179
OAAI
Meningococcal disease in the Middle East: A report from the Global Meningococcal Initiative

中东的脑膜炎球菌病: 全球脑膜炎球菌倡议的报告

2024-02-011
OAAI
Interferon-induced transmembrane protein-3 genetic variant rs12252 is associated with COVID-19 mortality

干扰素诱导的跨膜蛋白3遗传变异rs12252与新型冠状病毒肺炎死亡率相关

2021-07-0144
OAAI